InvestorsHub Logo
Post# of 251777
Next 10
Followers 1
Posts 302
Boards Moderated 0
Alias Born 06/13/2010

Re: None

Thursday, 07/31/2014 5:25:04 AM

Thursday, July 31, 2014 5:25:04 AM

Post# of 251777
ARRY from AZN PR today, notice anticipate first MEK Filling 2015:


selumetinib# SELECT-1
MEK inhibitor 2nd line KRAS+ NSCLC

Q4 2013 Ant. US file 2017 Ant. EU file2017

selumetinib# ASTRA
MEK inhibitor differentiated thyroid cancer

Q3 2013 Ant. US file 2017 Ant. EU file 2017

selumetinib# SUMIT
MEK inhibitor uveal melanoma

Q2 2014 Ant. US file 2015 Ant. EU file 2015

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.